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Background: To evaluate the spectrum of breast diseases and their association with presenting complains of
patients.
Methodology: It was a cross sectional study conducted from 1st January 2010 – 30th December 2012. A total of
254 breast specimens of patients, who were admitted in Civil Hospital Karachi with breast complaints, were
included. Specimens were collected either from mastectomy, lumpectomy or needle biopsy from the admitted
patients. Informed written consent was taken from all the patients. All patients with primary breast diseases were
included. Patients undergoing chemotherapy or with secondary breast disease and slides with insufficient specimen
were excluded. All data was entered and analyzed through SPSS 19.
Result: There were 254 breast lesions, histologically diagnosed in 3 year review period. The overall mean age of
patients with breast lesion was 25.18, SD ± 11.73 with a wide age range of 12–74 years. Most common cases
identified are benign 191(75.3%), followed by inflammatory 30(11.8%) and malignant lesions 30(11.8%). Most
patients presenting with the complain of pain have diagnosis of fibroadenoma 24 (63.2%) while patient with
complain of lump also have the most common diagnosis of fibroadenoma 147 (72.8%).
Conclusions: Study shows that in Pakistani females, mostly encountered breast lesion was fibroadenoma. Due to
lack of awareness breast diseases present lately. Awareness must be created among women to reduce the mortality
and morbidity with breast lesions.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1037059088969395.
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Breast diseases include inflammatory, benign and malig-
nant conditions. Around 200,000 cases of breast diseases
are diagnosed annually [1]. Breast diseases are more
prevalent among females as compared to males and the
pattern of breast diseases and their etiology varies
among different countries and ethnic groups [2].
Benign diseases can be classified as inflammatory, epi-
thelial and stroma proliferations, neoplasm and develop-
mental anomalies. Benign breast diseases are more
prevalent as compared to malignant and inflammatory,
as seen throughout the world [3]. Fibroadenomas are in* Correspondence: ribakumah@hotmail.com
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reproduction in any medium, provided the orgreater frequency among the population, constituting al-
most half of all cases of benign diseases [4]. Incidence of
benign lesions is common in the second decade reaching
on its peak at fourth and fifth decade of life [5]. Risk fac-
tors for benign and malignant breast diseases include
low parity, nulliparity, low age at first birth and late
menopause, highlighting the fact towards excessive cir-
culating estrogen levels [6,7].
Breast cancer is the most commonly diagnosed cancer
accounting for 23% of all diagnosed cancers and the
most common cause of death in women worldwide. It is
the fifth leading cause of death in both sexes combined
[8]. Breast cancer is one of the most frequently occur-
ring cancer and cancer related deaths are highly preva-
lent worldwide, which has become a major public healthtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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common malignancy in women accounting of 16% can-
cer in women. It has also been present as unknown ori-
gin tumor and also one of the first tumors to be ruled
out in the presence of tumor of unknown origin in
women. Immunohistochemistry is a diagnostic tool for
the classification of tumor and up to date several breast
markers has been postulate such as beta-catenin, FAK,
PIP, MUC1, PSE, e-cadherin, cytokeratin7 (CK7), estro-
gen and progesteron receptors, gross cystic disease fluid,
mammaglobin (MAG)-A and MAG-B [10]. Incidence of
malignant lesions is more frequent after menopause [5].
Breast problems for which patients consult doctors are
breast pain, nipple discharge and palpable masses.
Pathological or physiological nipple discharge is worri-
some. 10 to 15% of women with benign breast diseases
will complain of pathological nipple discharge. A breast
mass and a cyst need histological diagnosis whereas the
breast pain (mastalgia) remains the most common symp-
tom in women. A study at Illinois Chicago states that
36% of the women with breast cancer had breast pain
only [11].
In Pakistan there are no statistics available on breast
diseases hence studies are required to evaluate the inci-
dence and prevalence of breast diseases so that interven-
tions can be done to educate and guide people about the
risk factors and management strategies. Though a few
studies have been done in Pakistan regarding the breast
diseases but still there is a paucity of data through which
rising trend of breast disorders can be halted.
Our main objectives were to evaluate the spectrum of
breast diseases and evaluate their association with pre-
senting complains of the patient.
Methodology of breast
It is a cross sectional study, conducted between 1st
January 2010 to December 2012. A total of 254 breast
specimens of patients, who were admitted in Civil Hos-
pital Karachi with breast complaints, were included.
Specimens were collected either from mastectomy,
lumpectomy or needle biopsy from the admitted pa-
tients. All specimen were taken in 10% buffered formalin
and sent to the hispathological department of Dow Med-
ical College for histological analysis. The gross and cut
findings were noted and then the samples were placed in
respective cassettes and processed in concentration of
alcohol, embedded in paraffin and stained over glass
slide using Hematoxylin & Eosin dyes. All patients with
primary breast diseases were included. However the pa-
tients undergoing chemotherapy and secondary breast
disease were excluded.
In order to delineate the pattern of breast diseases
prevalent in Karachi, histopathological, cytological and
frozen section, diagnosis along with presenting complaintsand demographic data were collected in a pre-structured
questionnaire. Informed written consent was taken from
the patients and questions regarding the demographic
data and a detailed presenting complains were noted. The
specimens collected were classified into inflammatory,
benign and malignant breast lesions. Each slide was exam-
ined for diagnosis by two pathologists who have experi-
ence of greater than 10 years in this field. Any variation in
the diagnosis of the specimen by pathologists was con-
firmed again by the senior most pathologist of the path-
ology lab and the diagnosis in common was recorded. The
study was approved ethically by The Institutional Review
Board of Dow Medical College.
All the data was entered and analyzed through SPSS
19. Frequency and percentage were evaluated for cat-
egorical data. Mean and standard deviation were evalu-
ated for continuous data.
Result
There were 254 breast lesions, histologically diagnosed
in 3 year review period. The overall mean age of patients
with breast lesion was 25.18, SD ± 11.73 with a wide age
range of 12–74 years. Most common cases identified
were benign 191(75.3%) follow by inflammatory 30(11.8%)
and malignant lesions 30(11.8%) (Table 1).
Fibroadenoma is the most common lesion of benign
breast disease 181(71.3%) and it occurs mostly in 2nd
decade of life with a mean age of 20.56 ± 5.73. Phylloides
tumor, the other fibroepithelial tumor 3(1.2%) in the
series comprised cases occurring predominantly in the
second decade with a mean age of 28.66 ± 14.84 years
(Table 1).
Inflammatory lesions accounted for 30 (11.8%) cases.
Of these, breast abscess, acute mastitis, chronic mastitis
and breast ulcer reported for 9 (3.5%), 7 (2.8%), 7(2.8%)
and 2(0.8%) cases respectively (Table 1).
Malignant lesion comprised 30 (11.8%) cases. There
were only cases of invasive ductal carcinoma 30(11.8%)
which occurred in 4th decade with a mean age of 45.66 ±
11.63 years.
Of the 10(3.8%) cases of Breast diseases encountered
in males, all cases were of gynecomastia 10(3.8%). The
age range of patients with gynecomastia was 14–42 years,
with a mean of 26.20 years ± 10.45years and a peak inci-
dence in the third decade (Table 1).
Mostly cases presented with uni-lateral lesions 191
(75.2%). Most patients came with complain of lump 202
(79.5%) and pain 38(15%) in breast (Table 2).
Most patients with complain of pain have diagnosis of
fibroadenoma 24 (63.2%) and Invasive ductal carcinoma
5 (13.2%). Patients with presenting complain of breast
lump have mostly diagnose with Fibroadenoma 147
(72.8%) and Invasive ductal carcinoma 22 (10.9%)
(Table 3).
Table 1 Represents demographic data and pattern of breast diseases






a) Breast abscess 9 3.5 30.77 ± 8.77
b) Breast ulcer 2 0.8 37.50 ± 10.60
c) Acute mastitis 7 2.8 26.42 ± 10.65
d) Chronic mastitis 7 2.8 24.71 ± 6.44
e) Mammary duct ectasia 1 0.4 35
h)Granulomatous mastitis 4 1.6 30.26 ± 3.68
Total inflammatory lesions 30 11.9
3 Benign lesions
a) cystic changes 3 1.2 31.66 ± 10.40
b) fibrosis 4 1.6 35.25 ± 14.31
c) Fibrosis and adenosis 1 0.4 21
d) Epithelial hyperplasia 1 0.4 50
e) papillomas 1 0.4 35
g) Fibroadenoma 181 71.3 20.56 ± 5.73
h) Phyllodes tumor 3 1.2 28.66 ± 14.84
i) Accessory breast 1 0.4 40
Total benign lesions 191 75.3
4 Malignant lesions
b) Invasive ductal carcinomas 30 11.8 45.66 ± 11.63
Total malignant lesions 30 11.9
5 Male breast disease
Gynaecomastia 10 3.9 26.20 ± 10.45
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The incidence of breast disease has dramatically in-
creased over the last decade. Benign breast diseases are
a heterogeneous group of lesions, including a variety of
tissue abnormalities that are differentially associated
with breast cancer risk [1]. With the increase use of
mammography more and more, women are diagnosed
with benign and malignant breast diseases [12]. Breast
carcinoma is now the leading cause of cancer related
deaths in women worldwide after lung cancer. In the
year 2010 Breast cancer accounted for an estimated 28%
of all new cancer cases in United States [13].
Benign breast diseases are the most common breast le-
sions evaluate in this study. This was also the findings of
previous studies [1,4,14,15]. In this study, majority of bi-
opsies which were sent to histopathological department,
were of fibroadenomas. These findings reveal high rate
of lesions as compare to past studies [1,16-18]. Its peak
incidence is in 2nd and 3rd decade of life, but can alsooccur after menopause due to hormone replacement
therapy. These findings were consistent with other
studies [19].
In our study Phyllodes tumor accounts for 1.2% of all
the breast lesions and have a peak incidence in pre-
menopausal age. These findings were comparable with
other study also [19]. Phyllodes tumor present histologi-
cally as intraductal growth of intralobular stroma with
leaf life projections [19].
FIbrocytic change is one of the breast lesions with peak
range of incidence at 31–35 years. Our findings were con-
sistent with past study [1]. It occurs during ovulation and
just before menstruation. During these times, hormone
level changes, which often causes the breast cells to retain
fluid and develop into nodule or cyst which feels like a
lump when touched. These nodules and cysts spread
through out the breast. As hormone level rises just before
and during menstruation, mammary blood vessels swell,
alveoli expand and cell growth proliferates [1].






a) Unilateral 191 75.2
b) Bilateral 9 3.5
4 Symptomatology
a) pain 38 15
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much higher as compare to past studies [14-16]. All in-
flammatory lesions were revealed in early 30s with a
mean age from 24.7 ± 6.444 to 30.77 ± 8.77 for mastitis,
breast abscess and ulcer. Acute and chronic mastitis
constitute 5.8% of breast lesion which is in accordance
with past studies [16,20,21]. Similar to observation in all
past studies, gynecomastia was the most commonly en-
counter male breast disease constituting 3.9% of all the
cases, as indicate in previous studies [4,20]. Frequency of
Gynecomastia was found to be present on its peak in
2nd decade of life, which was earlier as compare to
African study [4]. It should not be considered as a
disease because enlargement of breast is a commonTable 3 Represents relation between diagnosis and complain
Diagnosis
Breast pain Brea
Breast abcsess 2 (5.3%) 7 (3.5
Acute mastitis 2 (5.3%) 6 (3%
Chronic mastitis 2 (5.3%) 7 (3.5
Mammary duct ectasia 1 (2.6%) 1 (0.5
Fat necrosis 0 0 (0%
Granulomatous mastitis 1 (2.6%) 4 (2%
Epithelial Hyperplasia (Proliferative breast
disessae without atypia)
0 (0%) 1 (0.5
Papillomas (Proliferative breast disessae
without atypia)
0 (0%) 1 (0.5
Invasive ductal carcinoma 5 (13.2%) 22 (1
Fibroadenoma (Stromal tumors) 24 (63.2%) 147 (
Phyloodes tumor (stromal tumors) 2 (5.3%) 3 (1.5
Accessory breast tissue 0 (0%) 1 (0.5
Gynaecomastia 2 (5.3%) 5 (2.5problem. Cause of gynecomastia in most cases is not
known, many being idiopathic. It mainly occurs due to
excessive estradiol related to testosterone [1]. Higher oc-
currence may be related to higher incidence of liver cir-
rhosis following hepatitis B, leading to hyperesterinism
and malignancy in susceptible males [18].
Granulomatous inflammatory changes in the breast
can be related to specific infectious agents such as Myco-
bacterium Tuberculosis, non-infectious disease such as
sarcoidoses, foreign material as silicon, paraffin or suture
material or trauma. It is present in pre-menopausal age. In
this study there were four cases of granulomatous mastitis,
which was comparable with the past study [1].
Breast cancer is the most common non-cutaneous
neoplasia in women. It is a heterogeneous disease, such
that it may have different prognostic and therapeutic re-
sponses despite similarities in histological types, grade
and stage of various subtypes. There are 19 subtypes of
breast carcinoma according to World Health Organization
(WHO) 2003 classification [22]. Mechanism of developing
breast cancer is still unclear but the contribution of muta-
tion in BRCA1 and BRCA2 have been reported to be asso-
ciated with a dominantly increased risk of disease [9].
Breast cancer susceptibility gene l (BRCA 1) is involved in
inhibition of cell growth, cell cycle regulation, gene tran-
scription, DNA damage repair and apoptosis. It was evalu-
ated that dislocation of the cytoplasmic BRCA1 protein in
breast cancer cells, is related to the occurrence and metas-
tasis of breast cancer and is expressed in cytoplasm of
breast cancer of both younger and elder people [23]. Es-
trogen, estrone, and estradiol are catabolized to catechol
estrogens and their metabolites, such as 4-hydroxyestrones of patients of breast disease
Symptomatology
st lump Nipple retraction fever Enlargement of
breast
%) 0 (0%) 0 (0%) 0 (0%)
) 0 (0%) 0 (0%) 0 (0%)
%) 0 (0%) 0 (0%) 0 (0%)
%) 0 (0%) 0 (0%) 0 (0%)
) 0 (0%) 2 (100%) 0 (0%)
) 0 (0%) 0 (0%)
%) 0 (0%) 0 (0%) 0 (0%)
%) 0 (0%) 0 (0%) 0 (0%)
0.9%) 1 (100%) 0 (0%) 1 (33.3%)
72.8%) 0 (0%) 1 (50%) 2 (66.7%)
%) 0 (0%) 0 (0%) 0 (0%)
%) 0 (0%) 0 (0%) 0 (0%)
%) 0 (0%) 1 (50%) 0 (0%)
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cinogenesis. Catechol-O-methyltransferase (COMT) cata-
lyzes the O-methylation of these carcinogenic estrogens to
methoxyes tradiols and methoxyestrones. Transition from
G to A in COMT gene results in an amino acid change
(Val/Met) at codon 108 of soluble COMT and codon 158
of membrane-bound COMT. This shifting in amino acids
has been result in a 3–4-fold decrease in enzymatic activ-
ity. It has been assesed that individuals who inherit the
low activity COMT gene may be at increased risk for
breast cancer, because of an increased accumulation of the
catechol estrogen intermediates, clearing the pathogenic
pathway of developing breast cancer [9]. A principal find-
ing of our study was malignancy rate of 11%, which were
consistent with past studies of Pakistan [15,24]. They were
not consistent with findings reported in study of Saudi
Arabia and Ghana [16,17]. Mean age of its presentation
was in 4th decade which was same as indicated in past
study [15]. In our study invasive ductal carcinoma be-
comes the most common and only variety of breast cancer
as indicated in past studies [2,24]. Invasive breast carcin-
oma is associated with a high mortality rate due to
invasion in lymph nodes, adjacent tissues and due to me-
tastasis. Invasive ductal carcinoma is the most common
histological type with a poor prognosis rate of 30-35% 10
year survival rate. Peritumor lymphatic and blood invasion
are the main factors related to presence of metastasis to
lymph nodes and they are more closely related to tumor
size and histological grade [25].
Most of the patients clinically present with lumps in
the breast followed by pain, enlargement of breast, fever
and nipple retraction. Our findings were comparable
with past studies [11,26,27].
We establish the baseline data for longitudinal study
prospective study and current study also adds additional
information to the international research literature. Our
study was a cross sectional study encircling a small part
of the population of Karachi and may not be representa-
tive of whole nation.
Breast cancer and breast diseases screening programs
should be developed at the hospitals. These programs
should ideally include clear objectives, plans and man-
agements. Programs should be free of cost, to encourage
large number of women to enroll in such screening
programs.Conclusion
Benign breast diseases are the commonest breast dis-
eases, in which fibroadenoma is the most common var-
iety. Cancer prevalence is less reported and invasive
ductal carcinoma is the most common reported variety.
Patients normally present late with locally advanced dis-
eases, due to lack of awareness and knowledge.Competing interests
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